Belay Diagnostics
Pre-clinicalCSF liquid biopsy testing for primary and metastatic CNS malignancies, providing clinicians and patients a minimally invasive alternative to tissue biopsy.
Founded
2019
Focus
DiagnosticsGenetics & Genomics
About
CSF liquid biopsy testing for primary and metastatic CNS malignancies, providing clinicians and patients a minimally invasive alternative to tissue biopsy.
Funding History
1Total raised: $304K
Grant$304KNINDSMay 30, 2024
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile